Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: experience from a regional head and neck unit

被引:46
作者
D'Souza, J. [1 ]
Lowe, D. [1 ,2 ]
Rogers, S. N. [1 ,2 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Reg Head & Neck Unit, Longmoor Lane, Liverpool L9 7AL, Merseyside, England
[2] Edge Hill Univ, Evidence Based Practice Res Ctr EPRC, Ormskirk, Lancs, England
关键词
Osteoradionecrosis; Debridement; Hyperbaric oxygen therapy; Medical management; Survival; HYPERBARIC-OXYGEN THERAPY; RADIONECROSIS; TRIAL; JAWS;
D O I
10.1016/j.bjoms.2014.01.003
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
This study is a retrospective review of treatment outcomes of osteoradionecrosis (ORN) of the mandible with specific reference to the evolving role of medical management with pentoxifylline, tocopherol, and doxycycline. We reviewed the presentation and management of 71 patientst reated for ORN of the mandible at the regional head and neck unit during a 15-year period to January 2011, and categorised them into three grades using the Notani classification: grade I (n = 28), grade II (n = 16), and grade III (n = 27). Twelve patients with grade I ORN, 3 with grade II, and 10 with grade III, were prescribed medical treatment. Of these, three with grade I, and two with grade II ORN were cured, and progression of the disease had halted and there was satisfactory control of symptoms in eight with grade I and four with grade III disease. Patients who failed to respond to conservative treatment were further analysed for the need for free flap reconstruction. Medical management was introduced as a standard treatment in January 2006. Of the 39 patients diagnosed before this, 20 (51%) required resection and free flap reconstruction compared with only 8/32 (25%) after it had been introduced. (C) 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:356 / 362
页数:7
相关论文
共 26 条
[1]  
Aitasalo K, 1998, HEAD NECK-J SCI SPEC, V20, P411, DOI 10.1002/(SICI)1097-0347(199808)20:5<411::AID-HED9>3.0.CO
[2]  
2-0
[3]   Hyperbaric oxygen therapy for radionecrosis of the jaw:: A randomized, placebo-controlled, double-blind trial from the ORN96 Study Group [J].
Annane, D ;
Depondt, J ;
Aubert, P ;
Villart, M ;
Géhanno, P ;
Gajdos, P ;
Chevret, S .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (24) :4893-4900
[4]   Hyperbaric oxygen therapy for late radiation tissue injury [J].
Bennett, Michael H. ;
Feldmeier, John ;
Hampson, Neil ;
Smee, Robert ;
Milross, Christopher .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (05)
[5]   The influence of hyperbaric oxygen on the outcome of patients treated for osteoradionecrosis: 8 year study [J].
D'Souza, J. ;
Goru, J. ;
Goru, S. ;
Brown, J. ;
Vaughan, E. D. ;
Rogers, S. N. .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 36 (09) :783-787
[6]  
David L A, 2001, J Can Dent Assoc, V67, P384
[7]   Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: A phase II trial [J].
Delanian, S ;
Depondt, J ;
Lefaix, JL .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (02) :114-123
[8]   The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway [J].
Delanian, S ;
Lefaix, JL .
RADIOTHERAPY AND ONCOLOGY, 2004, 73 (02) :119-131
[9]   COMPLETE RESTORATION OF REFRACTORY MANDIBULAR OSTEORADIONECROSIS BY PROLONGED TREATMENT WITH A PENTOXIFYLLINE-TOCOPHEROL-CLODRONATE COMBINATION (PENTOCLO): A PHASE II TRIAL [J].
Delanian, Sylvie ;
Chatel, Cecile ;
Porcher, Raphael ;
Depondt, Joel ;
Lefaix, Jean-Louis .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (03) :832-839
[10]   Patterns of treatment of osteoradionecrosis with hyperbaric oxygen therapy in the United Kingdom [J].
Dhanda, J. ;
Hall, T. J. H. ;
Wilkins, A. ;
Mason, V. ;
Catling, J. .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2009, 47 (03) :210-213